LONDON, July 17 (Reuters) - UK hospital group Spire
Healthcare IPO-SPIR.L is set to price its London stock market
debut at 210 pence a share, the bottom of the range and valuing
the firm at 842 million pounds ($1.4 billion), two sources
familiar with the matter said on Thursday.
Spire, which is owned by European private equity firm Cinven
CINV.UL , had set the original price range at 210-300 pence a
share, later narrowed to 210-220 pence, as it seeks to raise
gross proceeds of 315 million pounds through the sale of new
shares.
Sources told Reuters on Tuesday that books were covered for
the deal. Final pricing is set to be announced on Friday, when
unconditional trading will begin. ID:nL6N0PQ5FH
($1 = 0.5848 British Pounds)
(Reporting by Freya Berry; editing by Kirstin Ridley)
((freya.berry@thomsonreuters.com; +44207 5420214; Reuters
Messaging: freya.berry.thomsonreuters.com@reuters.net))
Keywords: SPIRE HEALTHCARE IPO